New procedure targets nerves to stop heart rhythm chaos

NCT ID NCT07501819

Not yet recruiting Disease control Sponsor: SymKardia Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tests a procedure that uses a catheter to ablate (destroy) a nerve near the heart, aiming to reduce signals that trigger ventricular tachycardia (VT), a dangerous fast heart rhythm. Ten adults with an implanted defibrillator (ICD) and recurrent VT will be enrolled. The main goals are to check safety and see if the procedure lowers the number of VT episodes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: catheter-based ablation of a sympathetic nerve near the heart
What this could lead to: If it works, this could offer a new way to control dangerous heart rhythms without long-term medication.
What could go wrong: This is a very early, small study (10 people) testing safety and feasibility, so it may not lead to a proven treatment. Risks include procedure-related complications like bleeding or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTRICULAR TACHYCARDIA (VT) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VENTRICULAR TACHYCARDIA (VT)

More trials for these conditions

Other studies related to the condition(s) this trial covers.